Jessica Burnside and Jeffrey Lazarus

and Learning Objectives 

• From NAFLD to SLD: Precision, Stigma, and Clinical Consequences (Tie to Diabetes/CASL guidelines) with Giada Sebastiani 
  1. Review the rationale and clinical implications of the transition from NAFLD to SLD nomenclature, including its impact on precision medicine, patient-centered care, and stigma reduction.
  2. Discuss the interplay between metabolic dysfunction, diabetes, and steatotic liver disease, with emphasis on risk stratification and fibrosis screening pathways.
  3. Apply current Diabetes Canada and CASL guideline recommendations for the identification and management of SLD in high-risk populations.
      
• Alcohol and SLD: Beyond Consumption to Risk Context with Jennifer Flemming
  1. Review the epidemiology and natural history of MetALD
  2. Discuss strategies on how to evaluate for alcohol consumption among patients with SLD
      
• Obesity, Metabolism, and the SLD Continuum with Michael Tsoukas
   
• Food and physical activity and Liver Health: The Hidden Drivers with Chantal Bémeur
  1. Explain how nutrition and physical activity influence liver health and contribute to the prevention of chronic liver disease;
  2. Identify key hidden lifestyle factors, including malnutrition, sedentary behaviour and muscle loss, that affect liver function and patient outcomes;
  3. Recognize evidence-based nutrition and physical activity strategies that can support liver health, quality of life, and disease management.